Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BISMUTH SUBSALICYLATE/ANTIBIOTIC COMBO FOR PEPTIC ULCERS

This article was originally published in The Tan Sheet

Executive Summary

BISMUTH SUBSALICYLATE/ANTIBIOTIC COMBO FOR PEPTIC ULCERS with the Helicobacter pylori bacterium was one of the treatments found effective by a National Institutes of Health consensus panel on Feb. 9. Specific treatments that have shown efficacy against H. pylori in clinical studies, according to the panel, include triple therapy with bismuth subsalicylate (Procter & Gamble's Pepto- Bismol), tetracycline and metronidazole; a triple regimen with metronidazole, amoxicillin and an H2 receptor antagonist; and double therapy with amoxicillin and Rx proton pump inhibitor omeprazole (Merck's Prilosec).
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082448

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel